REVTORPYK FDA approval date

The FDA approved REVTORPYK on 14 Jul 2026.

FDA approval date
14 Jul 2026

Drug identity has not yet been verified against registry records

Also recorded as GEDATOLISIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-07-14DayREVTORPYKFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA219908", "applicant_as_listed_by_fda": "CELCUITY", "brand_names": ["REVTORPYK"], "active_ingredients": ["GEDATOLISIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260714", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026